Phase 2 Trial of Consolidation Pembrolizumab After Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer
Nikhil Yegya‐Raman, Abigail T. Berman, Christine Ciunci, Cole Friedes, Eva Berlin, Michelle Iocolano, Xingmei Wang, Ching Tat Lai, William P. Levin, Keith A. Cengel, Shannon O’Reilly, Roger B. Cohen, Charu Aggarwal, Melina E. Marmarelis, Aditi P. Singh, Lova Sun, Jeffrey D. Bradley, John P. Plastaras, Charles B. Simone, Corey J. Langer, Steven J. Feigenberg
Topics & Concepts
MedicinePembrolizumabLung cancerOncologyInternal medicineCancerImmunotherapyLung Cancer Diagnosis and TreatmentCancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations